Healthcare Sales & Marketing Network News: Athenagen

Searching News Database: Athenagen

HSMN NewsFeed - 18 Jun 2007
CoMentis Receives FDA Clearance to Begin Human Clinical Trials for Its Disease-Modifying Alzheimer's Therapy
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Jun 2007
CoMentis Announces Appointment of Martin Tolar, M.D., Ph.D., as Vice President of Strategic and Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2007
CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 20 Feb 2007
Athenagen Announces Name Change to CoMentis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Sep 2006
Athenagen Raises $50 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 8 May 2006
Athenagen Announces the Appointment of John Donovan as Chief Financial Officer
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 3 additional stories matching:
Athenagen
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.